Stem Cell Therapeutics Corp.

CALGARY, ALBERTA–(Marketwire – March 30, 2009) – Stem Cell Therapeutics Corp. (the “Company” or “SCT”) (TSX VENTURE:SSS) announced today that Dr. Joshua M. Hare, MD, FACC, Louis Lemberg Professor of Medicine and Director, Interdisciplinary Stem Cell …

[Read the full article here]

Related News:
World-Renowned Stem Cell Pioneer to Speak in Coral Gables
Stem Cell Therapeutics Corp. Announces First Quarter 2009 Financial Results
Stem Cell Therapeutics Corp. Announces Completion of …

Leave a Reply